Crossmark

MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2

Crossref DOI link: https://doi.org/10.1186/s11658-018-0129-6

Published Online: 2019-02-05

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Qiang
License Information

Text and Data Mining valid from 2019-02-05
More Information

Article History

Received: 19 July 2018

Accepted: 4 December 2018

First Online: 5 February 2019

Ethics approval and consent to participate

: Patient samples were collected with written informed consent in accordance to the Declaration of Helsinki and all procedures performed in study involving human participants were approved by the ethics committee of the People’s Hospital of Xintai City (XT-2017-125–2017.10.21).

: Not applicable.

: The author declares that he/she has no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.